Agastiya Biotech is at the forefront of developing innovative small molecule therapeutics aimed at treating various forms of cancer and other diseases. Their flagship product, AB001, is a small molecule PDL1 immunotherapy that selectively targets and destroys tumors while sparing healthy cells, addressing a significant challenge in current cancer treatments that often result in toxicity. The U.S. FDA has granted Orphan Drug Designations for AB001 in the treatment of rare and aggressive cancers such as Glioblastoma, Pancreatic Cancer, and Acute Myeloid Leukemia. The company emphasizes the creation of toxicity-free small molecules, which not only enhances drug efficacy but also reduces the costs associated with drug development and approval processes.

In addition to cancer therapeutics, Agastiya Biotech is exploring the potential of AB001 as an antiviral treatment for SARS-CoV-2, demonstrating its ability to inhibit viral entry and replication with minimal toxicity. Their research extends to targeting cancer stem cells and genetic mutations, focusing on the underlying mechanisms of tumorigenesis and drug resistance. By leveraging an interdisciplinary approach, Agastiya Biotech aims to pioneer novel therapies that address unmet medical needs, particularly in the realm of cancer and chronic diseases, while also contributing to cost-effective healthcare solutions through their "Make in India" strategy.

United States

Agastiya Biotech merges advanced, Eastern knowledge with rigorous Western R&D in order to deliver breakthrough innovative pharmaceuticals to the marketplace.  Over 40% of all pharmaceutical drugs, including sophisticated chemotherapy and anti-viral drugs, are derived from natural plant sources.  Through investigation of ancient Eastern botanical knowledge combined with high throughput and AI driven analysis, Agastiya Biotech engineers best in class novel small molecules for treatment of disease. We are leading the discovery and design of ground-breaking small molecules to revolutionize medicine and find a cure for the diseases of our time.

Agastiya Biotech

Company Details